Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Pinsky

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
National Cancer Institute Monograph|December 1, 1973
Treatment of malignant melanoma by intratumoral injection of BCGC M Pinsky, Y Hirshaut, H F Oettgen
Annals of the New York Academy of Sciences|January 1, 1976
Delayed cutaneous hypersensitivity reactions and prognosis in patients with cancerC M Pinsky, H Wanebo, V Mike, et al.
Annals of the New York Academy of Sciences|January 1, 1976
Design of phase-I trials of immunopotentiators for cancer therapy: levamisole and Corynebacterium parvumY Hirshaut, C M Pinsky, H J Wanebo, et al.
Cancer|August 1, 1987
Toxicity of intravesical BCG and its management in patients with superficial bladder tumorsE Orihuela, H W Herr, C M Pinsky, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1984
Corynebacterium parvum toxicity in patients with limited and advanced malignancyY Hirshaut, C M Pinsky, H J Wanebo, et al.
Clinical Bulletin|January 1, 1978
Immunocompetence testing in patients with one of the four common operable cancers--a reviewH J Wanebo, C M Pinsky, E J Beattie, et al.
Urology|November 11, 1975
Study of local and systemic effects of intravesical BCGP F Schellhammer, M H Kaplan, C M Pinsky, et al.
Clinical Bulletin|January 1, 1976
Corynebacterium parvumL Delmonte, H F Oettgen, Y Hirshaut, et al.
Annals of the New York Academy of Sciences|January 1, 1976
Influence of poly (A)-poly (U) on immune response in cancer patientsH J Wanebo, M Kemeny, C M Pinsky, et al.
Clinical Chemistry|June 1, 1978
A preliminary evaluation of tissue polypeptide antigen in serum or urine (or both) of patients with cancer or benign neoplasmsC J Menendez-Botet, H F Oettgen, C M Pinsky, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
National Cancer Institute Monograph|December 1, 1973
Treatment of malignant melanoma by intratumoral injection of BCGC M Pinsky, Y Hirshaut, H F Oettgen
Annals of the New York Academy of Sciences|January 1, 1976
Delayed cutaneous hypersensitivity reactions and prognosis in patients with cancerC M Pinsky, H Wanebo, V Mike, et al.
Annals of the New York Academy of Sciences|January 1, 1976
Design of phase-I trials of immunopotentiators for cancer therapy: levamisole and Corynebacterium parvumY Hirshaut, C M Pinsky, H J Wanebo, et al.
Cancer|August 1, 1987
Toxicity of intravesical BCG and its management in patients with superficial bladder tumorsE Orihuela, H W Herr, C M Pinsky, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1984
Corynebacterium parvum toxicity in patients with limited and advanced malignancyY Hirshaut, C M Pinsky, H J Wanebo, et al.
Clinical Bulletin|January 1, 1978
Immunocompetence testing in patients with one of the four common operable cancers--a reviewH J Wanebo, C M Pinsky, E J Beattie, et al.
Urology|November 11, 1975
Study of local and systemic effects of intravesical BCGP F Schellhammer, M H Kaplan, C M Pinsky, et al.
Clinical Bulletin|January 1, 1976
Corynebacterium parvumL Delmonte, H F Oettgen, Y Hirshaut, et al.
Annals of the New York Academy of Sciences|January 1, 1976
Influence of poly (A)-poly (U) on immune response in cancer patientsH J Wanebo, M Kemeny, C M Pinsky, et al.
Clinical Chemistry|June 1, 1978
A preliminary evaluation of tissue polypeptide antigen in serum or urine (or both) of patients with cancer or benign neoplasmsC J Menendez-Botet, H F Oettgen, C M Pinsky, et al.
Pageof 7